Browsing Tag
Goldman Sachs
191 posts
Madison Air raises $2.25bn four months after IPO to fund $5bn ebm-papst acquisition
Madison Air has agreed to issue more than 90 million shares for approximately $2.25 billion, financing a large portion of its ebm-papst acquisition only months after an IPO that sharply reduced debt.
August 25, 2026
Marvell hands Google $12.2bn warrant to close hyperscaler custom silicon sweep
Marvell's $12.2bn Google warrant vests only against $120bn in cumulative custom silicon revenue, six times its current data centre run rate through fiscal 2033.
August 20, 2026
Goldman Sachs to buy LCN Capital Partners in up to $410m sale-leaseback deal
Goldman Sachs is paying up to $410m for LCN Capital Partners, adding a $3bn sale-leaseback platform in its second asset management deal in ten days.
August 19, 2026
Goldman Sachs strikes $2.25bn deal for options ETF specialist NEOS
Goldman Sachs will pay up to $2.25 billion for NEOS as active ETF flows heat up, but the price sets a high bar for what the deal delivers by 2027.
August 12, 2026
Dream Finders to acquire Beazer Homes, creating sixth-largest US homebuilder
Dream Finders raised its bid from $25.75 to $33.50 to secure Beazer at 0.8x book, but Beazer's Q3 loss and DFH's own margin squeeze make execution the test.
August 9, 2026
Prologis agrees £14.3bn SEGRO takeover in largest 2026 UK REIT deal
Prologis will pay up to £14.3 billion for SEGRO, but H1 2027 closing hinges on shareholder votes, regulatory clearances and a fresh $2.1bn equity raise.
August 6, 2026
Braveheart Bio IPO targets $1.2bn valuation as HCM drug race heats up
Braveheart Bio is seeking up to $318.8 million in its Nasdaq IPO, but investors must decide whether its cardiac myosin inhibitor can compete in an increasingly crowded hypertrophic cardiomyopathy market.
August 4, 2026
KKR takes Integer private for $5.7bn as device manufacturing growth slows
KKR’s $5.7 billion Integer deal offers a 52% premium as weaker near-term device sales contrast with durable manufacturing demand.
August 3, 2026
CBIZ to be taken private by Grant Thornton in largest US accounting M&A in 25+ years
Grant Thornton's $5B cash take-private of CBIZ at 54% premium arrives as Q2 EBITDA fell 14.3%; the only US-listed accounting firm now leaves the NYSE.
July 31, 2026
Oxylabs bets $3.6bn valuation on agentic AI web data infrastructure thesis
Warburg Pincus injects $130 million into Oxylabs at a $3.6 billion valuation, but can agentic AI data infrastructure defend that private-market benchmark?
July 23, 2026